News

The Commission is formulating its strategy on cluster development to boost innovation and maximise returns from structural funds and related budgets. But is there a policy recipe for a perfectly formed cluster?

By carefully manipulating materials at the nanoscale, researchers hope to devise more effective and personalised medical diagnostics and therapies.

As the Commission embarks on its ambitious lead markets project, it is becoming clear that handing out public money is not part of the plan.

The company that produces BlackBerry handhelds is to open an R&D facility on the campus of Ruhr-Universität Bochum, Germany.

The Transport Research Knowledge Centre has relaunched its web portal, making it easier to access results of EU or nationally financed transport research.

Innogenetics NV has settled its patent dispute with the US pharma giant Abbott over hepatitis C genotyping technology.

The European Society of Human Genetics wants to ban the patenting of genes and DNA sequences but allow patents on genetic tests.

The Innovative Medicines Initiative gets under way in earnest on 30 April when would-be participants will learn about the scope of the programme.